Brain Cancer Current Events | Brain Cancer News | 11
|
| Page
11 of
152 |
3025 Results |
|
|
|
Sort By:
Page Views | Date |
Scientists identify brain regions that decide where we look
Scientists have found the brain regions that decide where we look, and where to direct our eyes when we're faced with a difficult choice, such as looking someone straight in the eye or looking away. view more (2005-01-24)
UBC scientist unveils secret of newborn's first words
A new study could explain why "daddy" and "mommy" are often a baby's first words - the human brain may be hard-wired to recognize certain repetition patterns. view more (2008-08-27)
Sensitizing tumor response to cancer therapy
Two forms of skin and brain cancer respond very poorly to chemotherapy and radiation: melanoma and glioblastoma multiforme brain cancer. view more (2009-08-06)
Parts of brain involved in social cognition may be in place by age 6
Social cognition-the ability to think about the minds and mental states of others-is essential for human beings. In the last decade, a group of regions has been discovered in the human brain that are specifically used for social cognition. view more (2009-07-15)
UCLA discovery will aid in treatment of patients with a deadly brain cancer
Researchers at UCLA's Jonsson Cancer have identified key characteristics in certain deadly brain tumors that make them 51 times more likely to respond to a specific class of drugs than tumors in which the molecular signature is absent. view more (2005-11-10)
New gene silencing therapy for cervical cancer
Researchers at The University of Queensland's (UQ) Centre for Immunology and Cancer Research (CICR), based at the Princess Alexandra Hospital, have pioneered a new approach for the treatment of cervical cancer. view more (2005-11-17)
Reduced breast cancer risk: Physical activity after menopause pays off
Several studies had previously suggested that regular physical exercise reduces the breast cancer risk of women. However, it had been unknowned just how much exercise women should take in which period in life in order to benefit from this protective effect. Moreover, little was known about which particular type of breast cancer is influenced by... view more... (2009-01-16)
Moderate alcohol consumption enhances the formation of new nerve cells - may contribute to alcohol dependency
Moderate alcohol consumption over a relatively long period of time can enhance the formation of new nerve cells in the adult brain. The new cells could prove important in the development of alcohol dependency and other long-term effects of alcohol on the brain. The findings are published by Karolinska Institutet. view more (2005-04-26)
An excellent response to BNCT treatment in head and neck cancer
A Finnish research group has been the first in the world to publish an article in which BNCT treatment has had an excellent response in a patient with head and neck cancer for whom there was no other treatment available. The case report has been published in the June issue of the prestigious Radiotherapy and Oncology no. 72 (2004) pp. 83 - 84. view more (2004-09-14)
Can mental training games help prevent Alzheimer's?
Loss of thinking power is a fear shared by many aging baby boomers. That fear has resulted in a budding industry for brain training products - exercises such as Brain Age, Mindfit and My Brain Trainer - which in 2007 generated $80 million in the United States alone. view more (2009-03-11)
Blood-vessel blocker aids cancer-killing virus
Cancer-killing viruses are a promising therapy for incurable brain tumors, but their effectiveness has been limited in part because immune cells rapidly move in and eliminate them. view more (2007-11-28)
Increased levels of Muellerian-inhibiting substance could mean greater breast cancer risk
Women with increased levels of Müllerian inhibiting substance (MIS), best known for regulating in utero sexual differentiation in boys, may be at a greater risk for breast cancer. view more (2009-10-12)
Study suggests brain tumors need treatment with multiple 'targeted' drugs
Researchers at Dana-Farber Cancer Institute have shown that several, rather than just one, cell-growth switches are simultaneously overactive in many brain tumors and other solid tumors, explaining why treatment with just a single "targeted" switch-blocking drug often yields disappointing results. view more (2007-09-14)
Memory mission explores new territory in neuroscience
Astrophysicists peer into the far corners of deep space for dark matter, but for neuroscientists at the Queensland Brain Institute (QBI) exploring the unknown is much closer to home. view more (2008-11-21)
Media Registration: Europe`s largest breast cancer conference to be held in Barcelona
3rd European Breast Cancer Conference (EBCC-3) Palau de Congressos de Catalunya, Barcelona, Spain 19-23 March 2002 ABOUT EBCC-3"¦ * More than 3000 clinicians, scientists and patient advocates will attend. * Presentations will review new developments in molecular biology, epidemiology, prevention, diagnosis, treatment, psycho-social... view more... (2001-12-04)
New approach to gene therapy may shrink brain tumors, prevent their spread
Massachusetts General Hospital (MGH) researchers are investigating a new approach to gene therapy for brain tumors - delivering a cancer-fighting gene to normal brain tissue around the tumor to keep it from spreading. view more (2008-09-26)
Radioactive scorpion venom for fighting cancer
Health physicists are establishing safe procedures for a promising experimental brain-cancer therapy which uses a radioactive version of a protein found in scorpion venom. view more (2006-06-28)
Barrow researchers identify a new approach to detect the early progression of brain tumors
Researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center recently participated in a pilot study with the Montreal Neurological Institute that suggests a certain type of MRI scanning can detect when a patient is failing brain tumor treatment before symptoms appear. view more (2008-08-29)
Lead exposure leads to brain cell loss and damage years later
Eighteen years later, people who worked with lead have significant loss of brain cells and damage to brain tissue. view more (2006-05-23)
Cancer Research UK supports additional TroVax phase II trial in colorectal cancer
Oxford BioMedica announced today that Cancer Research UK (CRUK) has agreed to conduct and sponsor an open label Phase II trial with Oxford BioMedica's leading cancer immunotherapy product, TroVax®, in colorectal cancer patients who have liver metastases. The decision by CRUK follows extensive review of the successful Phase I/II data of TroVax... view more... (2003-08-28)
|
|
| Page
11 of
152 |
3025 Results |
|
|
|
Sort By:
Page Views | Date |
|
